Benecchi Christopher

Insider Reports History

Entity
Individual
Location
C/O Sage Therapeutics, Inc., 215 First Street, Cambridge, MA
Signature
Greg Shiferman, attorney in fact for BENECCHI CHRISTOPHER
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Benecchi Christopher:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Sage Therapeutics, Inc. Chief Operating Officer Common Stock 24.7K $222K $8.96 Nov 1, 2024 Direct
Sage Therapeutics, Inc. Chief Operating Officer Stock Option (Right to buy) 12.5K Nov 1, 2024 Direct

Insider Reports Filed by Benecchi Christopher

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SAGE Sage Therapeutics, Inc. Nov 1, 2024 2 $0 4 Nov 14, 2024 Chief Operating Officer
SAGE Sage Therapeutics, Inc. Aug 5, 2024 2 -$42.6K 4 Aug 7, 2024 Chief Business Officer
SAGE Sage Therapeutics, Inc. Feb 13, 2024 2 $0 4 Feb 15, 2024 Chief Business Officer
SAGE Sage Therapeutics, Inc. Feb 13, 2023 1 $0 4 Feb 15, 2023 Chief Business Officer
SAGE Sage Therapeutics, Inc. Feb 3, 2023 2 -$93.6K 4 Feb 7, 2023 Chief Business Officer
SAGE Sage Therapeutics, Inc. Jun 16, 2022 1 $0 4 Jun 21, 2022 Chief Commercial Officer
SAGE Sage Therapeutics, Inc. Feb 11, 2022 1 $0 4 Feb 15, 2022 Chief Commercial Officer
SAGE Sage Therapeutics, Inc. Oct 1, 2021 1 $0 4 Oct 4, 2021 Chief Commercial Officer
SAGE Sage Therapeutics, Inc. Sep 13, 2021 0 $0 3 Sep 13, 2021 Chief Commercial Officer